Literature DB >> 21319197

MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma.

Julia von Frowein1, Philipp Pagel, Roland Kappler, Dietrich von Schweinitz, Adelbert Roscher, Irene Schmid.   

Abstract

UNLABELLED: MicroRNAs (miRNAs) are well-known regulators of proliferation, apoptosis, and differentiation and are recognized to play an important role in the development of cancers. Here we aimed to identify the functional contribution of miRNAs to the biology of hepatoblastoma (HB), the most common malignant liver tumor in childhood. As overexpression of the oncogene PLAG1 (pleomorphic adenoma gene 1) is a characteristic phenomenon in HB, we used RNA interference and subsequent miRNA array analysis to identify miR-492 as most strongly influenced by PLAG1. We provide novel experimental evidence that miR-492 can originate from the coding sequence of the HB marker gene keratin 19 (KRT19). In agreement with these in vitro observations, significantly elevated levels of coexpressed KRT19 and miR-492 were particularly found in metastatic HB tumor samples. Stable overexpression of miR-492 in HB cell clones served to identify a broad range of differentially expressed transcripts, including several candidate targets of miR-492 predicted by computational algorithms. Among those the liver enzyme BAAT showed significant association with miR-492 expression in HB tumor samples.
CONCLUSION: A close functional relationship between KRT19 and miR-492 was identified that may play an important role in the progression of malignant embryonal liver tumors. Additionally, miR-492 and its associated targets might serve as new HB biomarkers of clinical utility and could assist to explore targeted therapies, especially in metastatic HB with a poor prognosis.
Copyright © 2010 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21319197     DOI: 10.1002/hep.24125

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  33 in total

1.  miR-492G>C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patients.

Authors:  Guopeng Yu; Qianyi Xiao; Xiao-Pin Ma; Xubo Chen; Zhuqing Shi; Lu-Yao Zhang; Haitao Chen; Pengyin Zhang; Dong-Lin Ding; Hui-Xing Huang; Hexige Saiyin; Tao-Yang Chen; Pei-Xin Lu; Neng-Jin Wang; Hongjie Yu; Jielin Sun; Carly Conran; S Lilly Zheng; Jianfeng Xu; Long Yu; De-Ke Jiang
Journal:  Tumour Biol       Date:  2016-01-11

2.  MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.

Authors:  Fei Shen; Wen-Song Cai; Zhe Feng; Jiang-Lin Li; Ji-Wei Chen; Jie Cao; Bo Xu
Journal:  Tumour Biol       Date:  2014-11-19

3.  MiR-492 is functionally involved in Oxaliplatin resistance in colon cancer cells LS174T via its regulating the expression of CD147.

Authors:  Lipan Peng; Huaqiang Zhu; Jinshen Wang; Haina Sui; Honglai Zhang; Changqing Jin; Leping Li; Tao Xu; Ruizheng Miao
Journal:  Mol Cell Biochem       Date:  2015-04-11       Impact factor: 3.396

4.  MicroRNA expression might predict prognosis of epithelial hepatoblastoma.

Authors:  Mónika Gyugos; Gábor Lendvai; István Kenessey; Krisztina Schlachter; Judit Halász; Péter Nagy; Miklós Garami; Zsuzsa Jakab; Zsuzsa Schaff; András Kiss
Journal:  Virchows Arch       Date:  2014-02-26       Impact factor: 4.064

5.  MicroRNA expression profiling of mature ovarian teratomas.

Authors:  Ye Ding; Xiao-Yan Gu; Feng Xu; Xiao-Yan Shi; DA-Zheng Yang; Jian Zhong; Su-Min Wang
Journal:  Oncol Lett       Date:  2011-10-12       Impact factor: 2.967

6.  βKlotho, a direct target of miR-206, contributes to the growth of hepatoblastoma through augmenting PI3K/Akt/mTOR signaling.

Authors:  Tong Chen; Jianglong Chen; Xiuhao Zhao; Jing Zhou; Qingfeng Sheng; Linlin Zhu; Zhibao Lv
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

7.  Myeloid zinc-finger 1 (MZF-1) suppresses prostate tumor growth through enforcing ferroportin-conducted iron egress.

Authors:  Y Chen; Z Zhang; K Yang; J Du; Y Xu; S Liu
Journal:  Oncogene       Date:  2014-10-06       Impact factor: 9.867

Review 8.  The role of microRNAs in the biology of rare diseases.

Authors:  Marco Salvatore; Armando Magrelli; Domenica Taruscio
Journal:  Int J Mol Sci       Date:  2011-10-11       Impact factor: 5.923

9.  miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs.

Authors:  Muhammad Riaz; Marijn T M van Jaarsveld; Antoinette Hollestelle; Wendy J C Prager-van der Smissen; Anouk A J Heine; Antonius W M Boersma; Jingjing Liu; Jean Helmijr; Bahar Ozturk; Marcel Smid; Erik A Wiemer; John A Foekens; John W M Martens
Journal:  Breast Cancer Res       Date:  2013-04-19       Impact factor: 6.466

10.  Identification of a set of miRNAs differentially expressed in transiently TIA-depleted HeLa cells by genome-wide profiling.

Authors:  Carmen Sánchez-Jiménez; Isabel Carrascoso; Juan Barrero; José M Izquierdo
Journal:  BMC Mol Biol       Date:  2013-02-06       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.